| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 59.84B | 45.53B | 47.24B | 56.34B | 62.09B |
| Gross Profit | 57.64B | 23.91B | 25.13B | 28.28B | 35.26B |
| EBITDA | 18.70B | 12.01B | 23.84B | 19.90B | 28.73B |
| Net Income | 11.13B | 13.94B | 17.63B | 21.97B | 21.48B |
Balance Sheet | |||||
| Total Assets | 509.50B | 501.78B | 508.88B | 514.82B | 556.71B |
| Cash, Cash Equivalents and Short-Term Investments | 41.74B | 36.07B | 42.48B | 61.20B | 63.37B |
| Total Debt | 64.54B | 57.63B | 60.72B | 62.02B | 110.91B |
| Total Liabilities | 108.75B | 101.58B | 109.45B | 129.04B | 178.37B |
| Stockholders Equity | 396.44B | 395.60B | 385.84B | 387.56B | 379.16B |
Cash Flow | |||||
| Free Cash Flow | 16.20B | 9.59B | -1.36B | 4.23B | 21.96B |
| Operating Cash Flow | 18.67B | 11.81B | 1.04B | 6.69B | 25.15B |
| Investing Cash Flow | 1.27B | -4.45B | -4.02B | 44.70B | -6.65B |
| Financing Cash Flow | -13.42B | -13.64B | -11.99B | -55.87B | -15.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$396.71B | 6.70 | 3.55% | 3.89% | 4.66% | 26.27% | |
74 Outperform | HK$169.88B | 12.36 | 2.75% | 4.33% | 27.01% | -20.16% | |
67 Neutral | HK$118.29B | 15.34 | 2.20% | 5.62% | 30.32% | -1.37% | |
66 Neutral | HK$229.62B | 3.64 | 8.80% | 5.18% | 2.11% | -0.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | HK$135.50B | 7.48 | 3.54% | 4.54% | -9.39% | -19.08% | |
51 Neutral | HK$73.16B | -34.25 | 0.03% | 1.76% | -9.23% | ― |